AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(From Chemical Business NewsBase - Dagens Industri)
Astra Zeneca has made an application to the FDA for approval of Nexium for the treatment of acute gastrointestinal side effects in patients who use non-steroidal antiinflammatory drugs (NSAID). Applications for approval of this indication are also on the way in Europe and Canada. The application is supported by two clinical studies which show that Nexium gives effective control of upper gastrointestinal tract symptoms caused by NSAID ...